What are Sanara MedTech Inc.'s total assets?

Sanara MedTech Inc. (SMTI) holds $69.3M in total assets, down 28.1% year over year.

How much debt does Sanara MedTech Inc. have?

Sanara MedTech Inc. carries $48.4M in total debt against $7.0M of shareholders' equity, a debt-to-equity ratio of 6.88.

How much cash does Sanara MedTech Inc. have?

Sanara MedTech Inc. holds $13.6M in cash and equivalents.

Can Sanara MedTech Inc. cover its short-term obligations?

Its current ratio is 2.28 — current assets exceed current liabilities.

Where does Sanara MedTech Inc.'s balance sheet data come from?

Every line is extracted from Sanara MedTech Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Sanara MedTech Inc. SMTI Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$13.59M-34.3%	$16.58M+4.4%	$14.94M-8.2%	$16.96M+465%	$20.69M+631%
Accounts receivable, net	——	——	——	——	-$368.28K-150%
Inventories	$3.12M-1.2%	$3.95M+43.4%	$3.39M+12.6%	$3.51M-1.5%	$3.16M-25.3%
Prepaid expenses and other current assets	$816.79K-25.1%	$948.62K-7.2%	$714.12K+66.3%	$1.2M+145%	$1.09M+19.7%
Assets held for sale	——	——	——	——	——
Total current assets	$31.2M-15.3%	$33.54M+0.7%	$31.23M-2.1%	$33.67M+61.8%	$36.84M+114%
Property and equipment, net	$458.88K-77.7%	$456.96K+5.7%	$417.21K-58.1%	$8.9M+697%	$2.06M+72.7%
Accumulated depreciation	$714.48K+31.4%	$672.87K+10.6%	$630.47K-60.4%	$588.91K-59.7%	$543.56K-59.1%
Operating lease right-of-use assets	13.3%+0.3%	13.3%+5.5%	13.3%+5.6%	13.2%+5.6%	13%+5.4%
Goodwill	$3.6M0.0%	$3.6M0.0%	$3.6M0.0%	$3.6M0.0%	$3.6M0.0%
Intangible assets, net	$17.86M-57.5%	$18.64M-54.5%	$21.1M-49.8%	$40.99M-4.6%	$42.01M-4.4%
Equity method investments	$13.16M+35.9%	$13.63M+161%	$11.59M+39.3%	$9.52M+209%	$9.69M+214%
Long-term investments	$14.16M—	$14.63M—	$12.59M—	$10.52M—	——
Total noncurrent assets	$38.08M-36.0%	$39.4M-28.1%	$39.86M-29.6%	$65.1M+23.8%	$59.54M+10.8%
Total assets	$69.28M-28.1%	$72.94M-17.2%	$71.09M-19.7%	$98.77M+34.6%	$96.38M+35.9%
Accounts payable	-$1.43M—	$1.17M—	——	——	——
Accrued expenses	——	——	——	——	——
Operating lease liabilities, current	$367.95K+60.2%	$353.23K-1.5%	$338.99K-22.8%	$182.94K-53.5%	$229.71K-39.1%
Liabilities held for sale	——	——	——	——	——
Total current liabilities	$13.7M+3.2%	$18.63M+21.8%	$17.36M+21.0%	$14.88M+28.6%	$13.28M+4.2%
Long-term debt	$46.23M+6.5%	$45.97M+49.8%	$45.09M+49.9%	$44.22M+208%	$43.4M—
Operating lease liabilities, non-current	$1.77M+62.8%	$1.87M+51.1%	$1.96M+39.5%	$1.05M-30.5%	$1.09M-33.1%
Operating Lease Liabilities (Total)	$2.14M+62.3%	$2.22M+39.2%	$2.3M+24.7%	$1.23M-35.3%	$1.32M-34.2%
Total noncurrent liabilities	$48.56M+4.6%	$48.39M+42.8%	$47.59M+36.9%	$48.5M+138%	$46.43M+206%
Total liabilities	$62.26M+4.3%	$67.01M+36.3%	$64.95M+32.3%	$63.38M+98.2%	$59.71M+114%
Common stock	20M0.0%	20M0.0%	20M0.0%	20M0.0%	20M0.0%
Additional paid-in capital	$81.52M+4.6%	$81.23M+5.3%	$79.83M+5.0%	$78.68M+4.8%	$77.97M+6.6%
Retained earnings	-$74.5M-80.3%	-$75.3M-99.3%	-$73.69M-103%	-$43.29M-29.7%	-$41.31M-38.2%
Noncontrolling interests	-$9.02K-163%	-$8.67K+98.2%	-$8.42K+97.4%	-$7.47K+97.5%	-$3.43K+98.8%
Total stockholders' equity	$7.03M-80.8%	$5.94M-84.9%	$6.15M-84.5%	$35.4M-15.1%	$36.67M-15.3%
Total liabilities and stockholders' equity	$69.28M-28.1%	$72.94M-17.2%	$71.09M-19.7%	$98.77M+34.6%	$96.38M+35.9%
Allowance for Doubtful Accounts	$6.69K+14.8%	$0-100%	$0-100%	$4.68K-99.3%	$5.83K-99.0%
Allowance for Doubtful Accounts Receivable (Current)	$1.45M+38.9%	$1.37M+16.9%	$1.32M+74.2%	$1.16M+25,972%	$1.04M+28,287%
Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)	$13.59M-34.3%	$16.58M+4.4%	$14.94M-8.2%	$16.96M+176%	$20.69M+631%
Contract Assets, Net	——	——	——	——	——
Other Inventory, Net	$508.31K+3.7%	$623.84K+16.7%	$666.89K+43.0%	$586.62K+25.5%	$490.24K+23.0%
Cost Method Investments - Original Cost	$1M0.0%	$1M0.0%	$1M-67.6%	$1M-67.6%	$1M-67.6%
Deferred Tax Assets and Other Non-Current Assets	——	——	——	——	——
Deferred Tax Assets - Tax Credit Carryforwards	——	——	——	——	——
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	$1.3M-64.2%	$1.83M-51.0%	$2.03M-45.5%	$3.63M-2.5%	$3.63M-2.6%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five)	$7.07M-64.4%	$8.49M-61.5%	$9.28M-58.0%	$19.87M-9.9%	$19.85M-10.0%
Indefinite-Lived Research and Development Assets	——	——	——	——	——
Net Investment in Lease	$1.99M+69.9%	$2.08M+43.4%	$2.15M+27.6%	$1.09M-39.3%	$1.17M-38.0%
Net Operating Loss Carryforwards	——	——	——	——	——
Intangible assets — net	$17.86M-57.5%	$18.64M-54.5%	$21.1M-49.8%	$40.99M-4.6%	$42.01M-4.4%
Other intangible assets—net	$17.86M-57.5%	$18.64M-20.6%	$21.1M-49.8%	$40.99M-4.6%	$42.01M-4.4%
Investments	$14.16M—	$14.63M—	$12.59M—	$10.52M—	——
Investments	$14.16M+32.5%	$14.63M+135%	$12.59M+51.3%	$10.52M+241%	$10.69M+247%
Operating lease right-of-use assets	$1.99M+69.9%	$2.08M+43.4%	$2.15M+27.6%	$1.09M-39.3%	$1.17M-38.0%
Property, plant and equipment at cost	$1.17M-54.9%	$1.13M+8.5%	$1.05M-59.5%	$9.49M+268%	$2.6M+3.2%
Operating Lease Right-of-Use Assets in Other Assets	$1.99M+69.9%	$2.08M+43.4%	$2.15M+27.6%	$1.09M-39.3%	$1.17M-38.0%
Other Investments	$1M0.0%	$1M0.0%	$1M-67.6%	$1M-67.6%	$1M-67.6%
Tax Credit Carryforward Valuation Allowance	——	——	——	——	——
Accrued Royalties (Current)	$2.62M-3.2%	$2.68M+18.5%	$2.66M+16.2%	$2.96M+19.7%	$2.7M+18.1%
Commissions and Contract Termination Costs	$9.08M+10.6%	$11.78M+16.8%	$10.88M+31.7%	$10.2M+51.9%	$8.21M+19.1%
Other accrued liabilities	——	——	——	——	——
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	$596.41K+105%	$631.29K+110%	$631.29K+66.3%	$291.22K-23.3%	$291.22K-23.3%
Operating Lease Liability Payments - 2025 (Lessee)	$521.81K+73.8%	$514.16K+73.9%	$514.16K+73.9%	$300.16K+1.5%	$300.16K+1.5%
Lease Liability Payments - Due Year Two	$596.41K+105%	$631.29K+110%	$631.29K+66.3%	$291.22K-23.3%	$291.22K-23.3%
Lease Liability Payments - Due Year Three	$514.16K+73.9%	$596.41K+105%	$596.41K+100%	$295.69K-0.8%	$295.69K-0.8%
Lease Liability Payments - Due Year Four	$521.81K+73.8%	$514.16K+73.9%	$514.16K+73.9%	$300.16K+1.5%	$300.16K+1.5%
Lease Liability Payments - Remainder of Fiscal Year	$631.29K+120%	$620K+32.8%	$620K+16.5%	$286.75K-46.1%	$286.75K-46.1%
Operating Lease Liability Payments Due	$2.86M+53.4%	$3.02M+54.0%	$3.17M+40.8%	$1.74M-25.8%	$1.87M-32.9%
Operating Lease Liability - Undiscounted Excess Amount	$722.63K+31.9%	$793.61K+119%	$868.9K+114%	$507.16K+15.1%	$547.92K-29.5%
Contingent Consideration Liability (Non-Current)	——	$235K-68.6%	$0-100%	$2.15M-42.5%	$771K-79.5%
Debt Maturity - 2027	$47.11M—	$46.93M—	$46.12M—	——	——
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$882.5K-22.1%	$956.04K-5.1%	$1.03M-3.5%	$1.1M+30.9%	$1.13M—
Deferred Tax Liabilities - Leasing Arrangements	——	——	——	——	——
Operating Lease Liability Payments - 2026 (Lessee)	$514.16K+73.9%	$596.41K+105%	$596.41K+100%	$295.69K-0.8%	$295.69K-0.8%
Operating Lease Liability Payments - 2027 (Lessee)	$131.89K-56.6%	$521.81K+73.8%	$521.81K+73.8%	$303.89K+1.2%	$303.89K+1.2%
Operating Lease Liability Payments - 2028 (Lessee)	$521.81K+73.8%	$514.16K+73.9%	$514.16K+73.9%	$300.16K+1.5%	$300.16K+1.5%
Operating Lease Liability Payments - 2029 (Lessee)	$131.89K-56.6%	$521.81K+73.8%	$521.81K+73.8%	$303.89K+1.2%	$303.89K+1.2%
Other Debt Including Capitalized Leases	$559.6K-52.1%	$548.13K-54.9%	$536.88K-57.4%	$1.12M-40.3%	$1.17M—
Other Secured Financings	——	——	——	——	——
Total debt	$48.37M+8.2%	$48.19M+49.3%	$47.39M+48.5%	$45.45M+179%	$44.72M+282%
Total Carrying Value of Debt	$47.11M+5.8%	$46.93M+48.0%	$46.12M+48.1%	$45.32M+198%	$44.53M—
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	9.2M+2.9%	8.9M+2.2%	8.9M+2.1%	8.9M+1.8%	8.9M+3.3%
Common Stock Shares Outstanding	$72K-88.6%	$135.04K-80.8%	$656.39K—	$552.8K—	$629.72K—
Additional paid-in capital	$81.52M+4.6%	$81.23M+5.3%	$79.83M+5.0%	$78.68M+4.8%	$77.97M+6.6%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$9.17K+2.9%	$8.95K+2.2%	$8.93K+2.2%	$8.9K+1.8%	$8.9K+3.3%
Number of Exercisable Options	10.2K-67.1%	10.2K-67.1%	31K0.0%	31K0.0%	31K-65.9%
Share-Based Payment - Nonvested Awards (Number)	423.6K—	258K—	279.5K—	——	——
Share-Based Payment Award Options Outstanding - Number	10.2K-67.1%	10.2K-67.1%	31K0.0%	31K0.0%	31K-65.9%
Share-Based Payment - Unrecognized Cost of Nonvested Awards	$25.46—	$34.99—	$34.91—	——	——
Weighted Average Exercise Price of Outstanding Options	$10.13-4.2%	$10.13-4.2%	$10.570.0%	$10.570.0%	$10.57+4.0%
Cumulative Cost Basis	$1.17M-54.9%	$1.13M+8.5%	$1.05M-59.5%	$9.49M+268%	$2.6M+3.2%
Licensing Arrangements	$2.62M-3.2%	$2.68M+18.5%	$2.66M+16.2%	$2.96M+19.7%	$2.7M+18.1%
Accounts Receivable, Allowance for Credit Loss	$1.45M+38.9%	$1.37M+16.9%	$1.32M+74.2%	$1.16M+25,972%	$1.04M+28,287%
Business Combination, Contingent Consideration, Liability	——	$235K-68.6%	$228K-94.2%	$2.15M-42.5%	$771K-79.5%
Cash and cash equivalents, end of period	$13.59M-34.3%	$16.58M+4.4%	$14.94M-8.2%	$16.96M+176%	$20.69M+631%
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$20M0.0%	$20M0.0%	$20M0.0%	$20M0.0%	$20M0.0%
Common stock, shares issued (in shares)	$9.17M+2.9%	$8.95M+2.2%	$8.93M+2.1%	$8.9M+1.8%	$8.9M+3.3%
Common Stock, Shares, Outstanding	$9.17M+2.9%	$8.95M+2.2%	$8.93M+2.1%	$8.9M+1.8%	$8.9M+3.3%
Contingent Consideration Liability	——	——	——	——	——
Long-term debt, gross	$47.11M+5.8%	$46.93M+48.0%	$46.12M+48.1%	$45.32M+198%	$44.53M—
Deferred Tax Assets Acquistion Liability	——	——	——	——	——
Deferred Tax Assets Depreciation And Amortization	——	——	——	——	——
Deferred Tax Assets, Gross	——	——	——	——	——
Deferred Tax Assets Lease Liability	——	——	——	——	——
Deferred Tax Assets, Operating Loss Carryforwards	——	——	——	——	——
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost	——	——	——	——	——
Powder Metal Matter	——	——	——	——	——
Accrued expenses	——	——	——	——	——
Deferred Tax Assets, Valuation Allowance	——	——	——	——	——
Deferred Tax Liabilities Contingent Liability	——	——	——	——	——
Deferred Tax Liabilities Depreciation And Amortization	——	——	——	——	——
Deferred Tax Liabilities Other Temporary Differences	——	——	——	——	——
Unrecognized compensation cost related to non-vested awards	$9.09M—	$5.69M—	$7.03M—	——	——
Equity Investment	——	——	——	——	——
Equity method investments (Note 11)	$13.16M—	$13.63M—	$11.59M—	——	——
2028	$2.32M-44.5%	$2.34M-39.7%	$2.54M-34.4%	$4.19M+8.3%	$4.18M+8.0%
2030	$1.3M-64.2%	$1.83M-51.0%	$2.03M-45.5%	$3.63M-2.5%	$3.63M-2.6%
2031	$1.3M-51.9%	$1.31M-64.7%	$1.52M-59.2%	$2.7M-27.4%	$2.7M-27.5%
Remainder of 2026	——	——	——	——	——
2027	$2.32M-45.9%	$2.34M-39.8%	$2.55M-34.5%	$4.3M+10.5%	$4.29M+10.2%
2029	$1.81M-56.3%	$2.34M-37.9%	$2.54M-32.4%	$4.14M+10.2%	$4.14M+10.2%
Finite Lived Intangible Assets Amortization Expense After Year Five	$7.07M-64.4%	$8.49M-61.5%	$9.28M-58.0%	$19.87M-9.9%	$19.85M-10.0%
Lessee Operating Lease Liability Payments Due	$2.86M+53.4%	$3.02M+54.0%	$3.17M+40.8%	$1.74M-25.8%	$1.87M-32.9%
Lessee Operating Lease Liability Undiscounted Excess Amount	$722.63K+31.9%	$793.61K+119%	$868.9K+114%	$507.16K+15.1%	$547.92K-29.5%
2029	——	——	——	——	——
Minimum Cash Balance Value	$3M—	$3M—	$3M—	$3M—	——
Noncontrolling interests in subsidiaries	-$9.02K-163%	-$8.67K+98.2%	-$8.42K+97.4%	-$7.47K+97.5%	-$3.43K+98.8%
Number Ofinvestments	——	——	——	——	——
Operating Lease Weighted Average Discount Rate Percent	$0.13+2.3%	$0.13+70.5%	$0.13+73.6%	$0.13+72.8%	$0.13+69.9%
Operating Loss Carryforwards	——	——	——	——	——
Other (including finance leases)	$559.6K-52.1%	$548.13K-54.9%	$536.88K-57.4%	$1.12M-40.3%	$1.17M—
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value	$25.46—	$34.99—	$34.91—	——	——
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	$10.22K-67.1%	$10.22K-67.1%	$31.01K0.0%	$31.01K0.0%	$31.01K-65.9%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$10.22K-67.1%	$10.22K-67.1%	$31.01K0.0%	$31.01K0.0%	$31.01K-65.9%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$10.13-4.2%	$10.13-4.2%	$10.570.0%	$10.570.0%	$10.57+4.0%
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number	$423.57K—	$257.99K—	$279.5K—	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$72K-88.6%	$135.04K-80.8%	$656.39K—	$552.8K—	$629.72K—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$10.13-4.2%	$10.13-4.2%	$10.570.0%	$10.570.0%	$10.57+4.0%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	$72K-88.6%	$135.04K-80.8%	$656.39K—	$552.8K—	$629.72K—
Remainder of Fiscal Year 2024	——	——	——	——	——
Remainder of Fiscal Year 2025	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Sanara MedTech Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Sanara MedTech Inc.'s total assets?: Sanara MedTech Inc. (SMTI) holds $69.3M in total assets, down 28.1% year over year.
How much debt does Sanara MedTech Inc. have?: Sanara MedTech Inc. carries $48.4M in total debt against $7.0M of shareholders' equity, a debt-to-equity ratio of 6.88.
How much cash does Sanara MedTech Inc. have?: Sanara MedTech Inc. holds $13.6M in cash and equivalents.
Can Sanara MedTech Inc. cover its short-term obligations?: Its current ratio is 2.28 — current assets exceed current liabilities.
Where does Sanara MedTech Inc.'s balance sheet data come from?: Every line is extracted from Sanara MedTech Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.